BARCELONA (EGMN) - Nearly half of women with metastatic breast cancer believe that any new treatment they start should increase their chances of survival by at least 1 year, compared with standard therapy. Oncologists have a much lower threshold, according to researchers who queried both groups on what they considered important when deciding on specific treatments.Survey data presented at the European Breast Cancer Conference showed that 48% of women with metastatic breast cancer expect a new treatment...